Alerts will be sent to your verified email
Verify EmailCHCL
Cian Healthcare
|
Venmax Drugs&Pharma
|
Beryl Drugs
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-2.49 % | -44.32 % | 2.54 % |
5yr average Equity Multiplier
|
2.79 | -0.19 | 2.23 |
5yr Average Asset Turnover Ratio
|
0.42 | 0.32 | 1.08 |
5yr Avg Net Profit Margin
|
-2.06 % | -30.94 % | 0.66 % |
Price to Book
|
0.0 | 3.42 | 1.16 |
P/E
|
49.54 | 0.0 | 49.26 |
5yr Avg Cash Conversion Cycle
|
-692.15 Days | 0.0 | -619.24 Days |
Inventory Days
|
163.23 Days | 24.83 Days | 36.1 Days |
Days Receivable
|
131.14 Days | 0.0 | 98.89 Days |
Days Payable
|
473.59 Days | 189.56 Days | 969.29 Days |
5yr Average Interest Coverage Ratio
|
0.8 | -318.36 | 1.68 |
5yr Avg ROCE
|
5.59 % | -45.33 % | 5.73 % |
5yr Avg Operating Profit Margin
|
14.07 % | -50.41 % | 7.19 % |
5 yr average Debt to Equity
|
1.12 | -0.64 | 0.64 |
5yr CAGR Net Profit
|
n/a | n/a | 72.78 % |
5yr Average Return on Assets
|
-0.86 % | 187.49 % | 1.31 % |
Shareholdings
|
|||
Promoter Holding
|
27.1 % | 23.13 % | 26.38 % |
Share Pledged by Promoters
|
34.48 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-43.79 % | 0.0 | 1.46 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Cian Healthcare
|
Venmax Drugs&Pharma
|
Beryl Drugs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|